Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added and revision v3.4.1 was removed.
    Difference
    0.0%
    Check dated 2026-02-14T12:39:30.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Posted results data for the PALOMA-3 study, including Ctrough and AUC Day 1-15 PK endpoints for Cycle 2 Day 1 and Cycle 4 Day 1, with regional notes and timing details. Deleted several earlier results metrics definitions that were previously shown.
    Difference
    2%
    Check dated 2026-02-07T07:49:07.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The changes update and standardize metadata display (glossary toggle, last update fields, FEAR Act labeling, and revision version) with some capitalization adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T03:08:07.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Results Submitted replaces No Results Posted on the study page, and the revision note updates to v3.3.4. This indicates that results for the study have been submitted.
    Difference
    0.0%
    Check dated 2026-01-17T01:24:48.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The Study Details page now displays 'Last Update Posted (Estimated)' instead of 'Last Update Posted', indicating that the update time may be approximate. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-26T20:31:22.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The Locations section now includes new entries across California, Colorado, Florida, Kansas, Michigan, New Jersey, New York, Oregon, Pennsylvania, South Carolina, Virginia, and Ontario. Some previously listed location sections were removed.
    Difference
    0.6%
    Check dated 2025-12-19T15:20:15.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.